The company's asset efficiency, represented by a robust -119.243% return, is a testament to Pangenomic Health Inc.'s adeptness in optimizing resource deployment. Pangenomic Health Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 19.820%. Furthermore, the proficiency of Pangenomic Health Inc. in capital utilization is underscored by a remarkable 1.828% return on capital employed.
Stock Prices
Pangenomic Health Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.08, while its low point bottomed out at $0.08. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Pangenomic Health Inc.'s stock market.
Liquidity Ratios
Analyzing NARA.CN liquidity ratios reveals its financial health of the firm.
The current ratio of 7.77% gauges short-term asset coverage for liabilities.
The quick ratio (5.87%) assesses immediate liquidity, while the cash ratio (0.63%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
7.77%
Quick Ratio
5.87%
Cash Ratio
0.63%
Profitability Ratios
The effective tax rate stands at -71.10%, revealing its tax efficiency.
The net income per EBT, 170.91%, and the EBT per EBIT, 352.41%, provide insights into its earnings hierarchy.
cards.indicator
cards.value
Effective Tax Rate
-71.10%
Net Income per EBT
170.91%
EBT per EBIT
352.41%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 0.08, it details the span from stock purchase to revenue.
cards.indicator
cards.value
Days of Sales Outstanding
6
Days of Payables Outstanding
25410
Payables Turnover
0.01
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.02, and free cash flow per share, -0.02, depict cash generation on a per-share basis.
cards.indicator
cards.value
Operating Cash Flow per Share
-0.02
Free Cash Flow per Share
-0.02
Free Cash Flow to Operating Cash Flow Ratio
1.00
Cash Flow Coverage Ratio
-2.54
Short Term Coverage Ratio
-2.54
Capital Expenditure Coverage Ratio
-506.05
Dividend Paid and Capex Coverage Ratio
-506.05
Debt and Leverage Ratios
Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 371.30%, highlights its total liabilities relative to assets.
With a debt-equity ratio of -0.34, we discern the balance between debt and equity financing.
An interest coverage of -130.76 indicates its ability to manage interest expenses.
cards.indicator
cards.value
Debt Ratio
371.30%
Debt Equity Ratio
-0.34
Total Debt to Capitalization
-52.18%
Interest Coverage
-130.76
Cash Flow to Debt Ratio
-2.54
Company Equity Multiplier
-0.09
Per Share Data
Net income per share, -0.22, reflects the portion of profit attributed to each share.
cards.indicator
cards.value
Net Income Per Share
-0.22
Growth Ratios
EBIT growth, -326.75%, and operating income growth, -326.75%, offer insights into operational profitability progression.
The net income growth, -667.33%, showcases bottom-line expansion, and the EPS growth, -494.59%, measures the growth in earnings per share.
cards.indicator
cards.value
Gross Profit Growth
-422.47%
EBIT Growth
-326.75%
Operating Income Growth
-326.75%
Net Income Growth
-667.33%
EPS Growth
-494.59%
EPS Diluted Growth
-494.59%
Weighted Average Shares Growth
31.78%
Weighted Average Shares Diluted Growth
31.78%
Operating Cash Flow Growth
-162.69%
Free Cash Flow Growth
-161.58%
10-Year Operating CF Growth per Share
-163.22%
5-Year Operating CF Growth per Share
-163.22%
3-Year Operating CF Growth per Share
-163.22%
10-Year Net Income Growth per Share
-3575.01%
5-Year Net Income Growth per Share
-3575.01%
3-Year Net Income Growth per Share
-3575.01%
10-Year Shareholders Equity Growth per Share
-154.74%
5-Year Shareholders Equity Growth per Share
-154.74%
3-Year Shareholders Equity Growth per Share
-154.74%
Receivables Growth
363.52%
Asset Growth
-80.44%
Book Value per Share Growth
-107.28%
R&D Expense Growth
311.90%
SGA Expenses Growth
320.24%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 25,494,307.08, captures the company's total value, considering both debt and equity.
Income quality, 0.23, assesses the reliability of reported earnings.
cards.indicator
cards.value
Enterprise Value
25,494,307.08
Income Quality
0.23
Capex to Operating Cash Flow
0.22%
Capex to Depreciation
-54.04%
Graham Number
0.11
Return on Tangible Assets
-4036.16%
Graham Net Net
-0.01
Working Capital
-234,882
Tangible Asset Value
-215,110
Net Current Asset Value
-234,882
Average Receivables
116,553.5
Average Payables
284,905
Days Payables Outstanding
13105
ROIC
5447.44%
ROE
94.59%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, -5.70, and the price to book ratio, -5.70, reflect the market's valuation relative to the company's book value.
Ratios like price to free cash flows, -0.74, and price to operating cash flows, -6.56, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
-5.70
Price to Book Ratio
-5.70
Price Cash Flow Ratio
-6.56
Enterprise Value Multiple
-0.17
Price Fair Value
-5.70
Price to Operating Cash Flow Ratio
-6.56
Price to Free Cash Flows Ratio
-0.74
Price to Tangible Book Ratio
-118.46
Enterprise Value Over EBITDA
-7.03
EV to Operating Cash Flow
-9.16
Earnings Yield
-79.86%
Free Cash Flow Yield
-10.94%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
